Salud financiera de hoja de balance de Archer Materials

Salud financiera controles de criterios 6/6

Archer Materials tiene un patrimonio de los accionistas total de A$24.4M y una deuda total de A$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son A$25.3M y A$961.2K respectivamente.

Información clave

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	AU$22.53m
Patrimonio	AU$24.36m
Total pasivo	AU$961.18k
Activos totales	AU$25.33m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$24.7M) de 38A superan a sus pasivos a corto plazo (A$926.1K).

Pasivo a largo plazo: Los activos a corto plazo de 38A (A$24.7M) superan a sus pasivos a largo plazo (A$35.1K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 38A está libre de deudas.

Reducción de la deuda: 38A no ha tenido ninguna deuda en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: 38A tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.

Pronóstico de cash runway: 38A dispone de suficiente cash runway para más de 3 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 9.7% cada año

Salud financiera de hoja de balance de Archer Materials

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Archer Materials Limited Designs Miniaturised Version of Biochip Biochip Graphene Field Effect Transistor Chip

Archer Materials Limited Demonstrates Multiplexing Readout for its Advanced Biochip Graphene Field Effect Transistor Device

Archer Materials Limited, Annual General Meeting, Nov 29, 2023

New major risk - Revenue size

Archer Materials Limited Further Enhances Biochip gFET Design for Advanced Sensing and Send to Commercial Foundry Partner

Archer Materials Limited Transfers Biochip Graphene Sensor Technology Design to A Commercial Fab to Verify Scalability

Archer Materials Limited Implements an Early-Stage Prototype of an Integrated Biochip Platform

Wettable Graphene Transistor Built for Biochip Integration

Archer Materials Limited, Annual General Meeting, Nov 23, 2022

Archer Materials Limited Uses Complementary MetalOxideSemiconductor Chip Technology to Detect Quantum Information in 12CQ Qubit Material at Room Temperature

Archer Materials Limited Announces On-Chip Electronic Transport in Qubit Components Achieved

Archer Materials Provides Shareholders with A Technical Progress Update on Archer's 12CQ

Archer Materials Limited Announces Fabrication of Nanodevices Towards Qubit Readout

Archer Materials Limited Announces Fabrication of Nanodevices Towards Qubit Readout

Archer Materials Limited Announces Biochip Progresses Towards Sub-10 Nanometer Fabrication

Archer Materials Limited Provides Update on Archer's 12CQ Quantum Computing Chip Technology

Independent Non-Executive Director Alice McCleary has left the company

Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.014 loss in FY 2020)

Archer Expands Access to Institutional Deep Tech Infrastructure

First half 2021 earnings released: AU$0.028 loss per share (vs AU$0.009 loss in 1H 2020)

New 90-day high: €0.80

Archer Materials Limited Achieves Electronic Transport in Single Qubit at Room Temperature, as Part of its 12CQ Quantum Computing Qubit Processor Chip Technology Development

Archer Materials Limited Announces the Granting of A Japanese Patent Associated to Archer's CQ Quantum Computing Chip Technology

New 90-day high: €0.37

New 90-day high: €0.36

Archer Materials Limited Announces the Resignation of Paul Rix as Non-Executive Director, Effective from 30 October 2020

Archer Materials Limited Provides Patent Applications Progress Update

Archer Materials Limited Appoints Ken Williams as an Independent Non-Executive Director and as A Member of the Archer Board’S Audit and Risk Management Committee

Full year earnings released - €0.014 loss per share

New 90-day high - €0.36

Australian Consolidated Venture Capital Pty Ltd completed the acquisition of Leigh Creek Magnesite Pty Ltd and CH Magnesite Pty Ltd from Archer Exploration Limited (ASX:AXE) for AUD 3 million.

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera